What changed?
A sourced timeline of research records and material development changes tracked by BACToBasics for AOD-9604. Research-publication dates and clinical-development event dates are labeled separately so they are not mistaken for the same type of update.
Tracked items
3
Research sources
2
Development entries
1
Latest recorded date
Verified 2026-09-05
Latest development activity
Verified 2026-09-05 · Phase 2 (historical) · Historical clinical development
AOD-9604 advanced into human obesity development through Phase 2-era studies, but the obesity program did not establish the efficacy needed to become an approved treatment and did not progress to approval.
Open source ↗Latest research record by publication date
Published 2026 · Review · Evidence review
The review places AOD-9604's human obesity-development history alongside the stronger evidence available for modern approved metabolic therapies.
Open source ↗Tracked timeline
Development changes are dated to the underlying milestone. Research-source entries use the study or source publication year currently stored in the Research Library; that year is not presented as the date BACToBasics added the record.
Phase 2 (historical) · Historical clinical development
AOD-9604 advanced into human obesity development through Phase 2-era studies, but the obesity program did not establish the efficacy needed to become an approved treatment and did not progress to approval.
Review · Evidence review
The review places AOD-9604's human obesity-development history alongside the stronger evidence available for modern approved metabolic therapies.
Preclinical · Preclinical animal study
Preclinical work explored the metabolic and lipolysis-related effects that originally motivated AOD-9604 development.
Following a compound creates a clean baseline from the updates currently known. When BACToBasics later records a new research source or material development change, the My Tools update badge can surface it as new for you.
BACToBasics provides educational research organization only. A development milestone does not predict future approval, and a research record does not establish that a compound is safe, effective, approved, or appropriate for use.